Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. - Wikidata - thesis-toulmin - TriplyDB

Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification.

Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification.

http://www.wikidata.org/entity/Q36572804

about

Factors associated with first-fill adherence rates for diabetic medications: a cohort study Educating resident physicians using virtual case-based simulation improves diabetes management: a randomized controlled trial.Ethnic differences in appointment-keeping and implications for the patient-centered medical home--findings from the Diabetes Study of Northern California (DISTANCE).Integrating depression and chronic disease care among patients with diabetes and/or coronary heart disease: the design of the TEAMcare study.Improving treatment intensification to reduce cardiovascular disease risk: a cluster randomized trial.Development and feasibility of a text messaging and interactive voice response intervention for low-income, diverse adults with type 2 diabetes mellitus The effectiveness of health coaching, home blood pressure monitoring, and home-titration in controlling hypertension among low-income patients: protocol for a randomized controlled trial.Comparing methods of measuring treatment intensification in hypertension care Impact of symptomatic hypoglycemia on medication adherence, patient satisfaction with treatment, and glycemic control in patients with type 2 diabetes.Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification?The association of patient-physician gender concordance with cardiovascular disease risk factor control and treatment in diabetes.Health systems, patients factors, and quality of care for diabetes: a synthesis of findings from the TRIAD study.The impact of removing financial incentives from clinical quality indicators: longitudinal analysis of four Kaiser Permanente indicators.The predictors of patient-physician race and ethnic concordance: a medical facility fixed-effects approach.International challenges without borders: a descriptive study of family physicians' educational needs in the field of diabetes The Chronic CARe for diAbeTes study (CARAT): a cluster randomized controlled trial.Treatment intensification and risk factor control: toward more clinically relevant quality measures.Quasi-experimental trial of diabetes Self-Management Automated and Real-Time Telephonic Support (SMARTSteps) in a Medicaid managed care plan: study protocol.Adherence to cardiovascular disease medications: does patient-provider race/ethnicity and language concordance matter?Prescription medication burden in patients with newly diagnosed diabetes: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study.Study protocol: the Adherence and Intensification of Medications (AIM) study--a cluster randomized controlled effectiveness study Initiation of treatment for incident diabetes: evidence from the electronic health records in an ambulatory care setting Contributors to primary care guidelines: What are their professions and how many of them have conflicts of interest?Using simulation technology to teach diabetes care management skills to resident physicians Patient complexity and diabetes quality of care in rural settings Health care system-level factors associated with performance on Medicare STAR adherence metrics in a large, integrated delivery system.Cost implications to health care payers of improving glucose management among adults with type 2 diabetes Patient-reported racial/ethnic healthcare provider discrimination and medication intensification in the Diabetes Study of Northern California (DISTANCE).Adherence to laboratory test requests by patients with diabetes: the Diabetes Study of Northern California (DISTANCE).Comparative effectiveness of early versus delayed metformin in the treatment of type 2 diabetes.Supporting Practices to Adopt Registry-Based Care (SPARC): protocol for a randomized controlled trial.Predictors of medication-related problems among medicaid patients participating in a pharmacist-provided telephonic medication therapy management program.Treatment adjustment and medication adherence for complex patients with diabetes, heart disease, and depression: a randomized controlled trial.Collaborative care for patients with depression and chronic illnesses.Reach and Validity of an Objective Medication Adherence Measure Among Safety Net Health Plan Members with Diabetes: A Cross-Sectional Study.Educational Outreach with an Integrated Clinical Tool for Nurse-Led Non-communicable Chronic Disease Management in Primary Care in South Africa: A Pragmatic Cluster Randomised Controlled Trial.Adherence to Antihypertensives in Patients With Comorbid Condition.Medicare Star excludes diabetes patients with poor CVD risk factor control.Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes A randomized controlled trial to provide adherence information and motivational interviewing to improve diabetes and lipid control.

P2860

Q24646987-B9E8236D-7097-4051-B810-559F41B48157 Q27318740-FB9F8EC4-0688-4D3D-8F26-D502741C084E Q30485208-7B3C98CF-14EB-400B-96F1-974F85112B65 Q30541872-962C59EF-B3D5-42C0-9465-C134479381CF Q31070536-7C2D0A90-69C3-4135-899C-E95291541325 Q33439766-85425E54-98C9-49D5-BD5B-05C45DDC3022 Q33517916-27214164-867E-4453-ACB6-530AFAAB23A3 Q33572437-375891BB-1712-4D96-84EB-4C184DAEA716 Q33573537-2EDBD54B-51A5-4DFD-9803-A8CC618613BA Q33606011-1378ABCD-DCAA-4876-BCD7-B87C8B16CB87 Q33686521-A76A4F00-E639-4C15-9BBF-0F66EDE19B15 Q33751647-24413F2E-5BAF-4D7B-99D0-1870CCC301EB Q33843937-72010D40-F120-4BD8-929A-BFD432238509 Q33874145-BBE5D560-B90A-45C6-A5A6-1AC3CDCE5DF3 Q33898660-62128000-4EDA-4E8C-B82C-6AD86B5F44B4 Q33986499-3A0C1D53-4F75-4B29-8539-66FE02E47A80 Q33988413-89088383-46B4-4D9C-BF29-E76D36FFF8E5 Q34142191-8C9AE217-DE42-4198-BBB1-E5BC2FA726CA Q34164232-9F75C8DA-ACD1-4678-A9AC-59C3578D03A0 Q34167629-292AFD79-6B76-40AE-8E39-3DBFF0B3C2F4 Q34258198-2860ADF7-4762-4876-B012-F72F1B9E087A Q34459227-68AC646C-A78B-4B4A-924E-931FA9C0DA55 Q34994802-363257CC-ED62-463D-A9CA-E0A7A1380F8D Q35017252-BE6DD5A3-7ED4-4DE3-B67F-38F4687D8175 Q35164296-6384A832-5D80-4764-AFDA-363D51C611F6 Q35177409-642CF2DD-0BF6-412F-8037-B4B830E08460 Q35190998-116CBD66-3AD1-4536-A922-10F5D0038E4B Q35235522-9BD93C18-7AA5-4B9C-B5CB-79D4B7E6FF0A Q35297627-4200E5DB-EBA3-432C-8BA6-DE00F43459C8 Q35305506-0F176484-B99D-44F5-B550-5B6A8E4C3756 Q35441326-0FB6A3EA-C211-4296-BAA9-514C12A74B3C Q35589861-36F33075-6F5E-45EE-9A75-3B399CF15113 Q35684156-0A47005B-0B85-49F7-801E-8C09E545FFA3 Q35854207-164B17BF-06E6-4E0C-B4A1-39E5CA08B64A Q36006414-B6DBEB33-966C-41C9-A3A4-0C3943B427AE Q36201056-148AF4F2-9CE7-42DA-92F5-AF454AF071BD Q36234696-AB513994-1357-41E1-9238-70B70AE5CA43 Q36270909-320BC6BC-EB85-44A5-A50E-FB0A91894E74 Q36484334-BF1BFD77-DDD4-42D6-8DC0-88B42362BE07 Q36490060-F0601A4F-8325-4061-8CBE-45D74087CCAA

P2860

Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification.

http://www.wikidata.org/entity/Q36572804

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Why don't diabetes patients ac ...... of treatment intensification.

@ast

Why don't diabetes patients ac ...... of treatment intensification.

@en

type

label

Why don't diabetes patients ac ...... of treatment intensification.

@ast

Why don't diabetes patients ac ...... of treatment intensification.

@en

prefLabel

Why don't diabetes patients ac ...... of treatment intensification.

@ast

Why don't diabetes patients ac ...... of treatment intensification.

@en

P1433

Q36572804-AF2D6364-3CC3-460D-8662-65012E76D9E5

P1476

Q36572804-C7215499-9651-4419-AE5D-C2C123A03283

P2093

Q36572804-0319C3DD-BDA0-40E7-9ED9-4FFB3497E06C

Q36572804-235787EE-C962-4E2F-BB53-EEAB6A7773DB

Q36572804-3CEF9144-37DA-4CAB-A912-3FBB97618C24

Q36572804-54536DC8-23C1-4D3A-9FB0-50097C544200

Q36572804-69A3B858-763C-4B94-BFCC-D05259972A0A

Q36572804-C03AC01B-C586-4F42-95E1-049D279B92A8

P2860

Q36572804-02AD45B0-ADE6-4CBD-A08A-C9B54A774150

Q36572804-09528144-2834-4386-B03B-7FC3EB143257

Q36572804-1081E03B-EEA0-4173-B292-44436A36DD75

Q36572804-1845A685-E3B0-4895-B39B-369AEC1AD073

Q36572804-20ED01F8-2C3E-4DE9-8870-67282364B3FC

Q36572804-3049D1C8-DD59-4A91-8054-83420BED62E7

Q36572804-36D43C32-F107-4966-A488-4523B2D4349A

Q36572804-3BE50F51-D297-435E-9C31-74ADAA0E42DE

Q36572804-3F7B9A42-830F-4A44-8ED1-5F3C29DA4DAC

Q36572804-5A6F67D8-BE24-4B6E-BD08-407625B31B30

P2888

Q36572804-42520A93-8341-4D1F-B7C3-17C19429EE5C

P304

Q36572804-8AC39B67-0E76-459F-A7EE-50E3316AF565

P31

Q36572804-EC674411-6874-455D-81FD-ECDA358EF93E

P356

Q36572804-355EBB66-F6EB-4258-989C-5F675D29E693

P433

Q36572804-A11CDF4B-9AC0-461A-B8CF-C669DCC69AAC

P478

Q36572804-411E52EC-CCA0-4E51-A484-A57EBA67304A

P50

Q36572804-AF17BD15-53BF-4C41-919C-B4D5246A650A

P577

Q36572804-27084D3C-DBBC-49D6-9680-20B616CFB198

P5875

Q36572804-6B76D48C-9A5C-4462-B78E-87112D543A6D

P698

Q36572804-40AD947F-4F83-48EA-B5CA-B4B0D9136EE9

P921

Q36572804-64D77F22-80C2-4AD9-A781-22A0A67AAB53

P932

Q36572804-7DB560F3-C599-463C-ACFB-25716789EDA7

P356

S11606-008-0554-8

P1433

Journal of General Internal Medicine

P1476

Why don't diabetes patients ac ...... of treatment intensification.

@en

P2093

Andrew J Karter

http://www.w3.org/2001/XMLSchema#string

Carol M Mangione

http://www.w3.org/2001/XMLSchema#string

Connie S Uratsu

http://www.w3.org/2001/XMLSchema#string

Joe V Selby

http://www.w3.org/2001/XMLSchema#string

Julie A Schmittdiel

http://www.w3.org/2001/XMLSchema#string

Usha Subramanian

http://www.w3.org/2001/XMLSchema#string

P2860

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study

Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002

Adherence with statin therapy in elderly patients with and without acute coronary syndromes

Hypertension in adults across the age spectrum: current outcomes and control in the community

Adherence to Medication

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Clinical outcomes and adherence to medications measured by claims data in patients with diabetes

P2888

s11606-008-0554-8

P304

588-594

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11606-008-0554-8

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Michele Heisler

P577

2008-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5534102

http://www.w3.org/2001/XMLSchema#string

P698

18317847

http://www.w3.org/2001/XMLSchema#string

P921

P932

2324158

http://www.w3.org/2001/XMLSchema#string